Induction of cyclooxygenase-2 and invasiveness by transforming growth factor-β1 in immortalized mouse colonocytes expressing oncogenic ras

Journal of Gastrointestinal Surgery

Volumn 6, Issue 3, 2002, Pages 304-309

  Roman, Christopher D ^a   Morrow, Jason ^a   Whitehead, Robert ^a   Beauchamp, R Daniel ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Carcinogenesis; Cyclooxygenase 2; Immortomouse; Transforming growth factor

Indexed keywords

ANTIGEN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ICOSANOID; PROSTACYCLIN; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1; ISOENZYME; PROSTAGLANDIN SYNTHASE; PROTEIN P21; TGFB1 PROTEIN, MOUSE; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INDUCTION; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; INHIBITION KINETICS; INTESTINE CELL; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE RAS; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; REGULATORY MECHANISM; ANIMAL; CELL CULTURE; COLON; COLORECTAL TUMOR; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; COLON; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; ISOENZYMES; MICE; ONCOGENE PROTEIN P21(RAS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0036580482     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)00041-5     Document Type: Article

References (46)

1. Beauchamp RD, Peeler MO, DuBois RN. Recent advances in the management of colorectal polyps. Curr Opin Gastroenterol 1996;12:12-17.
2. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-716.
3. DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD. GI delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996;56:733-737.
4. Kudo T, Narisawa T, Abo S. Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. Gann 1980;71:260-264.
5. Pollard M, Luckert PH. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 1981;214:558-559.
6. Thun MJ, Namboodiri NM, Health CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-1596.
7. Giovannucci E, Egan KM, Hunter DG, Stampfer MJ, Colditz GA, Willet WC, Speizer FE. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-614.
8. Smalley W, Ray WA, Daugherty J, Griffin MR. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: A population-based study. Arch Intern Med 1999;159:161-166.
9. Labayle D, Fischer D, Viehl P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-639.
10. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-1316.
11. Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993;80:1618-1619.
12. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 1996;87:803-809.
13. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997;99:2254-2259.
14. Sheng H, Shao J, Dixon DA, Williams CS, Prescott SM, DuBois RN, Beauchamp RN. Transforming growth factor-beta 1 enhances Ha-Ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem 2000;275:6628-6635.
15. Matsura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J, Jettem AM. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 1999;274:29138-29148.
16. Jones MK, Sasaki E, Halter F, Pai R, Nakamura T, Arakawa T, Kuroki T, Tamawski AS. HGF triggers activation of COX-2 gene in rat gastric epithelial cells: Action mediated through the ERK2 signaling pathway. FASEB 1999;13:2186-2194.
17. Xie W, Herschman HR. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J Biol Chem 1996;271:31742-31748.
18. Xie W, Herschman HR. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun-N-terminal kinase and the c-Jun transcription factor. J Biol Chem 1995;270:27622-27628.
19. Perkins DJ, Kniss DA. Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells. Biochem J 1997;321:677-681.
20. Sheng H, Williams CS, Shao J, Liang P, DuBois RN, Beauchamp RD. Induction of cyclooxygenase-2 by activated Haras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J Biol Chem 1998;273:22120-22127.
21. Subbaramiah K, Chung WJ, Dannenberg AJ. Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 1998;273:32943-32949.
22. Massague J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-791.
23. Engel ME, Datta PK, Moses HL. RhoB is stabilized by transforming growth factor β and antagonizes transcriptional activation. J Biol Chem 1998;273:9921-9926.
24. Hata A, Shi Y, Massague J. TGF-β signaling and cancer: Structural and functional consequences of mutations in Smads. Mol Med Today 1998;4:257-262.
25. Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A. High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 1995;4:549-554.
26. Beauchamp RD, Lyons RM, Yang EY, Coffey RJ Jr, Moses HL. Expression of and response to growth regulatory peptides by two human pancreatic carcinoma cell lines. Pancreas 1990;5:369-380.
27. Arteaga CL, Carty-Dugger T, Moses HE, Hurd SD, Pietenpol JA. Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ 1993;4:193-201.
28. Sun L, Wu G, Willson JK, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang WF, Brattain MG. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 1994;269:26449-26455.
29. Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp Cell Res 1989;181:442-453.
30. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987;327:298-303.
31. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-297.
32. Filmus J, Zhao J, Buick RN. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-β1) and alters the number and type of TGF-beta-1 receptors in rat intestinal epithelial cell clones. Oncogene 1992;7:521-526.
33. Winesett MP, Ramsey GW, Barnard JA. Type II TGF (beta) receptor expression in intestinal cell lines and in the intestinal tract. Carcinogenesis 1996;17:989-995.
34. b-tsA58 transgenic mice. Proc Natl Acad Sci USA 1993;90:587-591.
35. Saha D, Datta PK, Sheng H, Morrow JD, Wada M, Moses HI, Beauchamp RD. Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta 1 and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia 1999;1:508-517.
36. Gilbert RS, Reddy ST, Kujubu DA, Xie W, Luner S, Herschman HR. Transforming growth factor beta 1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 cells and in murine embryo fibroblasts. J Cell Physiol 1994;159:67-75.
37. Gilbert RS, Reddy ST, Targan S, Herschamn HR. TGF-beta 1 augments expression of the TIS10/prostaglandin synthase-2 gene in intestinal epithelial cells. Cell Mol Biol Res 1994;40:653-660.
38. Sheng H, Shao J, Hooton EB, Tsujii M, DuBois RN, Beauchamp RD. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. Cell Growth Differ 1997;8:463-470.
39. 1 treatment results in downregulation of the type II TGF-β receptor and induction of cyclooxygenase-2. Oncogene 1999;18:855-867.
40. Tsujii M, Dubois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
41. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-3340.
42. Heasley LE, Thaler S, Nick M, Price B, Skorecki K, Nemenoff RA. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J Biol Chem 1997;272:14501-14504.
43. Caulin C, Scholl FG, Frontelo P, Gamallo C, Quintanilla M. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ 1995;6:1027-1035.
44. Zambruno G, Marchiso PC, Marconi A, Vascieri C, Melchiori A, Giannetti A, De Luca M. Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: Implications for wound healing. J Cell Biol 1995;129:853-865.
45. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-beta 1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996;10:2462-2477.
46. Oft M, Heider KH, Beug H. TGF-beta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998;8:1243-1252.